• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Hydroxy-PEG12-Boc

CAS No. 2388521-20-6

Hydroxy-PEG12-Boc ( Hydroxy-PEG12-T-Butyl Ester )

产品货号. M26967 CAS No. 2388521-20-6

Hydroxy-PEG12-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
10MG ¥300 有现货
25MG ¥454 有现货
50MG ¥591 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Hydroxy-PEG12-Boc
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Hydroxy-PEG12-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • 产品描述
    Hydroxy-PEG12-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • 同义词
    Hydroxy-PEG12-T-Butyl Ester
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    eNOS; iNOS; nNOS
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2388521-20-6
  • 分子量
    674.8
  • 分子式
    C31H62O15
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CC(C)(C)OC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Maggi CA, et al. Effect of NG-monomethyl L-arginine (L-NMMA) and NG-nitro L-arginine (L-NOARG) on non-adrenergic non-cholinergic relaxation in the circular muscle of the human ileum. Br J Pharmacol. 1991 Aug;103(4):1970-2.
产品手册
关联产品
  • L-Gulono-14-lactone

    L-Gulono-14-lactone is a substrate of L-gulono-14-lactone oxidoreductase which catalyzes the last step of the biosynthesis of L-ascorbic (Vitamin) C.

  • Neoartanin

    Neoartanin is a betaine pigment isolated from the fresh root of red beet with antioxidant capacity.

  • DCZ0415

    DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.